The Valley Desk

NCT01365455 · Interventional trial

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Overall registry status Completed

Phase 3

Conditions Moderate to Severe Plaque-type Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov